Imagine 2035: Your daughter wears a bracelet that early reports subtle changes in heart rate variability and blood pressure—long before a risk of illness arises. Precision prevention is then everyday life: personalized exercise recommendations, nutrition that reduces inflammation, and coaching that optimizes stress and sleep. This future starts today. Those who understand how the female heart presents differently and what protects it lay the foundation for a long, energetic life—and for the health of the next generation.

Cardiovascular diseases are common among women, but the warning signs are often quieter. Instead of the "classic" chest pressure, symptoms such as fatigue, shortness of breath, nausea, or pain in the back, jaw, or upper abdomen occur—signals that can easily be overlooked in daily life. Visceral fat visceral fatadipose tissue around internal organs promotes inflammation and increases blood pressure and LDL cholesterol. Heart rate variability HRVfluctuations between heartbeats; marker for the balance of the autonomic nervous system reflects resilience and stress regulation. A sustained dominance of the sympathetic nervous system sympathetic nervous system"accelerator" of the autonomic nervous system increases blood pressure, inflammation, and the risk of arrhythmia. High-performing women benefit from a precise focus on these markers: Those who know their HRV, blood pressure, and lipid levels can manage risks early—and stabilize performance.

A sedentary lifestyle weakens the vascular system and increases mortality and cardiovascular events—especially after menopause. Women who are sufficiently active and sit less have significantly lower risks of overall and cardiovascular mortality compared to inactive women who sit for long periods ^[1]. Even small changes in behavior matter: Frequent transitions from sitting to standing improved blood pressure markedly in a study within three months ^[2]. Smoking—even e-cigarettes—damages blood vessels through oxidative stress, disrupts the autonomic nervous system (HRV decreases), and thus increases heart risk ^[3]. Conversely, successful smoking cessation substantially reduces risk for both genders, with clear predictors for abstinence when support is structured ^[4]. Those who actively manage their blood pressure and cholesterol also gain: data from a large mHealth cohort show that high-risk individuals often do not achieve targets despite medication—indicating that more intensive and consistent therapy and self-tracking are necessary ^[5]. Nutrition has a dual effect: trans fats worsen lipids and increase cardiometabolic risks, sometimes more pronounced in women ^[6]. Omega-3 fatty acids provide anti-inflammatory effects; however, combined EPA+DHA in moderate doses showed no clear reduction in MACE in heterogeneous patient groups, while high-dose EPA may be promising in subgroups but could be associated with more atrial fibrillation—making individual benefit-risk assessment necessary ^[7].

Several recent studies sharpen the view on female risk profiles. A large analysis of postmenopausal women linked sufficient recreational activity and lower sitting times to significantly lower overall and cardiovascular mortality; notably, the combined effect: those who optimize both have the lowest risk. Randomized data complement this mechanistically: An intervention arm with more frequent sit-stand transitions reduced blood pressure within three months—an everyday lever that positively influences vascular load and autonomic tone [Ref42019429; Ref40709462].
Smoking emphasizes the role of the autonomic nervous system. A review shows that combustion and e-cigarettes reduce HRV globally due to oxidative stress—an indication of sympathetic dominance and increased cardiovascular risk. Thus, HRV not only becomes a risk marker but also a potentially modifiable target through lifestyle changes and smoking cessation ^[3]. In a nationwide evaluation of cessation programs for high-risk patients, abstinence was realistically achievable; structured support, pharmacological assistance, and repeated contacts increased success rates— a practice-relevant indication of how prevention functions in real life ^[4].
Finally, the "therapy target delta" comes into focus: In a German mHealth cohort with app-based monitoring, high-risk groups less frequently achieved their blood pressure and cholesterol targets compared to low-risk groups, despite being treated more often. This suggests that the intensity and quality of therapy (e.g., adequate statin dosing, combinations) and consistent self-tracking are crucial, not just the prescriptions alone ^[5].

- Movement as a daily ritual: Plan for 150–300 minutes of moderate activity per week (e.g., brisk walking, cycling) plus 2 strength sessions. Every movement counts—even below the guidelines, risks noticeably decrease ^[8].
- Anti-sitting strategy: Stand up every 30–45 minutes, walk for 1–2 minutes, or aim for 20 sit-stand transitions per day. Even more frequent transitions significantly lower blood pressure ^[2].
- Smoke-free with a system: Set a quit date, use medical support and effective cessation medications, and arrange at least four follow-up appointments—the chances of success increase significantly ^[4]. Also, avoid e-cigarettes: both lower HRV and shift the autonomic balance unfavorably ^[3].
- Know your numbers, meet your goals: Measure blood pressure at home 3–4 days/week, document values in an app, and have lipid levels checked quarterly to semi-annually. With high-risk profiles, question the therapy dose (e.g., high-intensity statins or combinations) with your doctor—otherwise, high-risk groups often miss target values ^[5].
- Nutrition with cardiovascular benefits: Consistently eliminate industrial trans fats (ingredients: "hydrogenated"/"partially hydrogenated" fats) and reduce added sugars. Both worsen lipids and increase cardiometabolic risk, sometimes more significantly in women ^[6].
- Targeted use of Omega-3: 2–3 fish meals per week or EPA/DHA from algal oil are advisable. Supplements: combined moderate EPA+DHA showed no clear MACE reduction in heterogeneous groups; high-dose pure EPA may help in selected high-risk cases but requires medical consideration due to potential AF risk over 1.5 g/day ^[7].
- Evaluate alcohol soberly: Constant low amounts were associated with a lower risk in observational data, but no causality—avoid "protection through alcohol" as a strategy. Those who drink heavily or erratically increase risk and mortality; reduction pays off ^[9].

In the coming years, wearables, mHealth, and more precise lipid and inflammation profiles will connect prevention with real-time management. We can expect studies that integrate HRV, personalized exercise, and targeted lipid therapies specifically for women—with the goal of fewer silent risks and more years in full performance.